Showing results 5 to 12 of 12
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2022 | |||
Homologous and heterologous boosting with third-dose BNT162b2 and CoronaVac: a randomized trial (Cobovax study) Proceeding/Conference:Options for the Control of Influenza XI | 2022 | ||
1-Mar-2023 | |||
Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents Journal:Nature Communications | 2022 | ||
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents Journal:Nature Communications | 2022 | ||
2021 | |||
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection Journal:Nature Immunology | 2020 | ||
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection Journal:Nature Communications | 2021 |